Torsten Zimmermann
Bayer (Germany)(DE)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Medical Imaging Techniques and Applications, Antibiotics Pharmacokinetics and Efficacy, Retinal Development and Disorders, Uterine Myomas and Treatments
Most-Cited Works
- → Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls(2011)96 cited
- → In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients(2013)83 cited
- → In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106(2013)74 cited
- → The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial(2018)55 cited
- → Long‐Term Azithromycin Therapy in Cystic Fibrosis Patients: A Study on Drug Levels and Sputum Properties(2004)51 cited
- → Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples(1992)41 cited
- → Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women(2012)31 cited
- → Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study(2011)30 cited
- → Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential(2018)29 cited
- → The Pharmacokinetics of Extended‐Release Formulations of Calcium Antagonists and of Amlodipine in Subjects with Different Gastrointestinal Transit Times(1999)28 cited